Non Invasive Prenatal Testing Market Introduction:

Non Invasive Prenatal Testing Market is estimated to value over USD 9 billion by 2027 end and register a CAGR of over 12.3% during the forecast period 2020 to 2027.

Increasing growth in reimbursements for the NIPT sector, rising usage of non-invasive methods drive the non invasive prenatal testing market growth. Additionally, non-invasive parenteral testing products and development and launch of new and advanced technologies fuel the market growth. However, ethical hurdles and a dearth of skilled professionals as well as stringent regulatory guidelines slow down the process of marketing and approvals, thus restraining the non-invasive prenatal testing market growth. The emergence of a new market in Asia-Pacific has untapped potential to make way for profitable opportunities for this market.

The cell-free DNA (cfDNA) in maternal plasma tests segment is projected to witness significant non invasive prenatal testing market growth over the forecast period. This high growth is due to increasing company initiatives to develop new products and technological advancements.

China is anticipated to remain a significant opportunity for non-invasive prenatal screening, with over 16 million births annually, out of which over 800,000 come under the high-risk pregnancy category.

Furthermore, there is a reduction of delineation between average and high-risk pregnancies, which is expected to stimulate the volumetric capabilities.

Key market players are:

Illumina Inc., Thermo Fisher Scientific Inc., GE Healthcare, Perkinelmer Inc., Agilent Technologies Inc., Beijing Genomics Institute, F. Hoffmann-La Roche Ltd., Laboratory Corp. of America Holdings, Natera Inc. and Yourgene Health.

Non Invasive Prenatal Testing Market Segmentation:

By Product & Service

  • Consumables
  • Assay Kits & Reagents
  • Disposables
  • Instruments
  • Ultrasound Devices
  • Next-Generation Sequencing Systems
  • Polymerase Chain Reaction Instruments
  • Microarrays
  • Other Instruments
  • Services

By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

By End User

  • Diagnostic Laboratories
  • Hospitals

By Region

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis 
  • Key trends 
  • Key data-points affecting market growth   

Objectives of the Study:

  • To provide with an exhaustive analysis on the global non invasive prenatal testing market by product & service, by method, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics